Compare BSX & FANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSX | FANG |
|---|---|---|
| Founded | 1979 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.8B | 55.3B |
| IPO Year | 2010 | 2012 |
| Metric | BSX | FANG |
|---|---|---|
| Price | $50.04 | $201.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 22 | 24 |
| Target Price | $93.18 | ★ $213.82 |
| AVG Volume (30 Days) | ★ 19.8M | 1.7M |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 2.05% |
| EPS Growth | ★ 55.20 | N/A |
| EPS | 1.51 | ★ 6.72 |
| Revenue | $9,076,000,000.00 | ★ $15,026,000,000.00 |
| Revenue This Year | $11.85 | $12.05 |
| Revenue Next Year | $10.16 | N/A |
| P/E Ratio | $32.46 | ★ $30.60 |
| Revenue Growth | 12.49 | ★ 35.79 |
| 52 Week Low | $42.20 | $134.30 |
| 52 Week High | $109.50 | $216.90 |
| Indicator | BSX | FANG |
|---|---|---|
| Relative Strength Index (RSI) | 51.91 | 53.84 |
| Support Level | $47.17 | $186.95 |
| Resistance Level | $50.14 | $204.91 |
| Average True Range (ATR) | 1.47 | 4.95 |
| MACD | -0.23 | 0.36 |
| Stochastic Oscillator | 16.63 | 58.59 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Diamondback is a crude oil and natural gas exploration and production firm whose operations represent a pure-play in the US Permian Basin. The company went public in 2012 and has established itself as a top-tier independent producer through disciplined acquisition and operational excellence. The company's most transformational transaction occurred in September 2024 with the completion of its $26 billion merger with Endeavor Energy Resources, which added around 470,000 net acres and doubled Diamondback's total acreage position. Diamondback boasts an enviable position in the Midland sub-basin, with some of the lowest unit costs among its Permian peers.